Related content

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

By Katz Matthew  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 836-847

Springer Publishing Company

Access to resources Recommend Favorite

The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration

By Prell Rodney   Gearin Lisa   Simmons Andrew   VanRoey Melinda   Jooss Karin  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1285-1293

Springer Publishing Company

Access to resources Recommend Favorite

Elevated Preoperative Neutrophil-to-lymphocyte Ratio as a Predictor of Survival After Gastroenterostomy in Patients with Advanced Pancreatic Adenocarcinoma

By Sugiura Teiichi   Uesaka Katsuhiko   Kanemoto Hideyuki   Mizuno Takashi   Okamura Yukiyasu  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4330-4337

Springer Publishing Company

Access to resources Recommend Favorite

Current state of adjuvant therapy in resected pancreatic adenocarcinoma

By Bergenfeldt Magnus   Albertsson Maria  

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 124-135

Informa Healthcare

Access to resources Recommend Favorite

Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine

By Hueman Matthew   Stojadinovic Alexander   Storrer Catherine   Dehqanzada Zia   Gurney Jennifer   Shriver Craig   Ponniah Sathibalan   Peoples George  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 2, 2007-02 ,pp. : 135-146

Springer Publishing Company

Access to resources Recommend Favorite